What is the role of belimumab (Benlysta) in the treatment of lupus nephritis?

Updated: Mar 04, 2019
  • Author: Lawrence H Brent, MD; Chief Editor: Vecihi Batuman, MD, FASN  more...
  • Print

Belimumab (Benlysta) is an anti–B-lymphocyte stimulator [BLyS] monoclonal antibody). [68] It has been found to have beneficial effects on clinical and laboratory parameters in patients with active SLE. [69] In addition, the number of B cells and serum IgM were reduced over time. [70]

Belimumab was approved by the US Food and Drug Administration (FDA) for use in patients with active SLE who are autoantibody-positive and are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives, and NSAIDs.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!